9JR-16831-36611
5 vaccinations
2 coded responses
28 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 920 / CA
- Registered
- 2021-01-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-13
Registered in v-safe
-
2021-01-13
Dose 1 — Moderna
- 2021-01-13
-
2021-01-14
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Redness, Swelling · Abdominal painAdult check-in
-
2021-01-16
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
-
2021-01-17
Survey response — days 1–6 daily, dose 1MedDRA: Migraine — Feeling: Good · Site: Pain · Headache, NauseaFree text: Probably related to migraine, not vax.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-18
- 2021-01-19
- 2021-01-22
- 2021-01-27
- 2021-02-03
-
2021-02-10
Dose 2 — Moderna
- 2021-02-10
-
2021-02-11
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · NauseaAdult check-in
- 2021-02-12
-
2021-02-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Itching · HeadacheAdult check-in
- 2021-02-14
- 2021-02-15
- 2021-02-16
- 2021-02-17
- 2021-02-24
- 2021-03-03
- 2021-03-11
- 2021-03-17
- 2021-03-24
- 2021-05-12
- 2021-08-11
-
2021-08-23
Dose 3 — ModernaCo-administered: Flu
- 2022-02-10
-
2022-03-24
Dose 4 — Moderna
-
2022-06-27
Survey response — 3 months, dose 4MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Covid-19MedDRA releases: 2024-11 · check-in free text available
-
2022-06-27
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-06-28
- 2022-09-22
-
2022-09-23
Dose 5 — ModernaCo-administered: Flu
- 2023-03-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-13 | Moderna | |
| 2 | 2021-02-10 | Moderna | |
| 3 | 2021-08-23 | Moderna | Flu |
| 4 | 2022-03-24 | Moderna | No |
| 5 | 2022-09-23 | Moderna | Flu |
Call center
1 call center case
1 unsuccessful
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Probably related to migraine, not vax.
Release 12 — 3 months, dose 4
Symptoms: Covid-19
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SRO | Migraine | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release